Opinion: Why prescription drugs in Canada could soon become less safe

Health Canada needs to forgo greater pharma industry influence and return to parliamentary funding for new drug approvals.
Source: APStock

In a little-noticed announcement, Health Canada in October 2017 signaled its intention to raise the fees that drug makers will have to pay when they want to get a new medication on the market.

These user fees currently fund about 50 percent of Health Canada’s operating budget for regulating prescription drugs. Health Canada wants to increase that to 90 percent. In addition, it will rebate 25 percent of that fee if it fails to review new drug applications within an established period of time.

On the surface, charging companies for public services seems to make sense. After all, riders on public transit

You're reading a preview, sign up to read more.

More from STAT

STAT3 min read
An Experimental AI System Can Predict When Pancreatic Cysts Will Become Cancerous
Pancreatic cancer is often deadly because it is detected too late. A new AI system outdoes humans at diagnosing which cysts are cancerous.
STAT5 min readSociety
WHO Declares Ebola Outbreak An International Health Emergency
The WHO declared the Ebola outbreak in the DRC a global health emergency, a move that is likely to escalate international attention on a crisis that has flared for a…
STAT5 min readSociety
Debate Over Whether To Test A Second Ebola Vaccine Turns Acrimonious
An aggressive push to use a second experimental Ebola vaccine to try to help stop the outbreak in the Democratic Republic of the Congo may have backfired.